The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
Authors
Keywords
Pirfenidone, Cisplatin, Non-small cell lung cancer, Cancer associated fibroblasts
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-03
DOI
10.1186/s12885-016-2162-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy
- (2015) Seo-Hyun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
- (2014) Gabor Valcz et al. JOURNAL OF CLINICAL PATHOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
- (2014) Maimon C. Rose et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
- (2014) Martin Augsten Frontiers in Oncology
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
- (2013) Melanie Mediavilla-Varela et al. CANCER BIOLOGY & THERAPY
- Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells
- (2013) S. Kozono et al. CANCER RESEARCH
- Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity
- (2013) Youn-Hee Choi et al. EXPERIMENTAL EYE RESEARCH
- Inhibition of Pirfenidone on TGF-beta2 Induced Proliferation, Migration and Epithlial-Mesenchymal Transition of Human Lens Epithelial Cells Line SRA01/04
- (2013) Yangfan Yang et al. PLoS One
- Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
- (2012) Ji-Ye Yin et al. PLoS One
- Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells
- (2012) Keiko Hisatomi et al. BMC Pulmonary Medicine
- In Vitro Effects of Pirfenidone on Cardiac Fibroblasts: Proliferation, Myofibroblast Differentiation, Migration and Cytokine Secretion
- (2011) Qiang Shi et al. PLoS One
- Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias
- (2010) Duy T. Nguyen et al. HEART RHYTHM
- Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast
- (2009) Maike Sonnenberg et al. BMC CANCER
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
- (2008) Hisashi Oku et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search